Survival outcome of intermediate risk neuroblastoma at Children Cancer Hospital Egypt

Conclusion A very high rate of survival is currently achievable in patients with intermediate risk neuroblastoma by chemotherapy or chemotherapy and surgery. In addition to response, our plan is to adopt biologically-based treatment to reduce treatment-induced complications among survivors.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research